RSV vaccination uptake among adults aged 60 years and older in the United States during the 2023–2025 vaccination seasons

RSV vaccination uptake among adults aged 60 years and older in the United States during the 2023–2025 vaccination seasons

Older adults and adults with certain chronic conditions are at increased risk for severe respiratory syncytial virus (RSV) disease. In 2023, RSV vaccines first became available in the United States (US) for adults aged ≥60 years. This retrospective database analysis evaluated RSV vaccination uptake...

Full description

Saved in:
Bibliographic Details
Main Authors: Elizabeth M. La, Catherine B. McGuiness, David Singer, Marie Yasuda, Chi-Chang Chen
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Vaccination uptake
respiratory syncytial virus
adjuvanted RSVPreF3 vaccine
RSVpreF vaccine
older adults
disparities
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2025.2535755
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items